Featured Research

from universities, journals, and other organizations

Antibodies together with viral 'inducers' found to control HIV in mice

Date:
August 14, 2014
Source:
Rockefeller University
Summary:
Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body’s immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated.

Antibody cocktail. Rockefeller’s Ariel Halper-Stromberg with a vial containing broadly neutralizing antibodies. When combined with compounds that induce viral replication, the antibodies prevented the HIV virus from “rebounding” in mice.
Credit: Image courtesy of Rockefeller University

Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body's immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated.

Related Articles


But a new strategy devised by researchers at Rockefeller University harnesses the power of broadly neutralizing antibodies against HIV, along with a combination of compounds that induce viral transcription, in order to attack these latent reservoirs of cells in an approach termed "shock and kill." In tests on mice, 57 percent of animals treated in this way did not have the expected resurgence of virus in their blood after their treatment ended.

"This is the first time that any combination of agents has been found to prevent viral rebound in any animal model," says Michel C. Nussenzweig, who oversaw the research.

Three Rockefeller labs collaborated on the study: Nussenzweig's Laboratory of Molecular Immunology; Alexander Tarakhovsky's Laboratory of Immune Cell Epigenetics and Signaling; and Jeffrey V. Ravetch's Leonard Wagner Laboratory of Molecular Genetics and Immunology. The findings are published August 14 in Cell.

The problematic latent reservoirs of HIV-infected cells are established very early in the infections, possibly even before tests can detect the presence of the virus, and current drug therapies are unable to kill the latent cells.

"The latent reservoir remains the major barrier to curing HIV-1 infection," says Nussenzweig, who is the Zanvil A. Cohn and Ralph M. Steinman Professor and a Howard Hughes Medical Institute investigator. "Our finding suggests that antibodies could play a significant role in disrupting the establishment and maintenance of the latent reservoir, which is believed to be a necessary step to curing patients of HIV-1."

The Nussenzweig lab has worked for several years on broadly neutralizing antibodies, a recently discovered subset of antibodies with an unusually high ability to recognize HIV consistently despite the virus's ability to rapidly mutate. Broadly neutralizing antibodies have shown great promise for treating HIV infection in mouse and monkey models of HIV. But by themselves they suffered the same problem that plagued other therapies: when you stop administering them, the virus rebounds.

Counterintuitively, the key to success in this instance was combining broadly neutralizing antibodies with viral inducers, compounds that prompt latent viruses to become active by promoting the transcription of their DNA. The idea is to eliminate the invisibility of the latent reservoir while simultaneously attacking the virus. More than half of the mice that received broadly neutralizing antibodies along with a cocktail of three viral inducers had no viral rebound at all, even three-and-a-half months after their last injection. (Broadly neutralizing antibodies alone, or even in combination with a single viral inducer, did not have this effect, nor did combinations of anti-retroviral drugs and viral inducers that have been attempted in the past.)

The researchers say that one reason broadly neutralizing antibodies may have succeeded where traditional drugs have failed is their ability to directly harness the power of the body's own immune system using Fc receptors, which occur on a wide variety of immune system attack cells and help them precisely target the infection.

"A big surprise in this study was the important role the Fc part of the antibody played in amplifying the potency of broadly neutralizing antibodies," says Ravetch, who is Theresa and Eugene M. Lang Professor. "Their effect in neutralizing latent reservoirs of HIV-1 was largely driven by Fc-receptor binding."


Story Source:

The above story is based on materials provided by Rockefeller University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ariel Halper-Stromberg, Ching-Lan Lu, Florian Klein, JoshuaA. Horwitz, Stylianos Bournazos, Lilian Nogueira, ThomasR. Eisenreich, Cassie Liu, Anna Gazumyan, Uwe Schaefer, RebeccaC. Furze, MichaelS. Seaman, Rab Prinjha, Alexander Tarakhovsky, JeffreyV. Ravetch, MichelC. Nussenzweig. Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice. Cell, 2014; DOI: 10.1016/j.cell.2014.07.043

Cite This Page:

Rockefeller University. "Antibodies together with viral 'inducers' found to control HIV in mice." ScienceDaily. ScienceDaily, 14 August 2014. <www.sciencedaily.com/releases/2014/08/140814191231.htm>.
Rockefeller University. (2014, August 14). Antibodies together with viral 'inducers' found to control HIV in mice. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2014/08/140814191231.htm
Rockefeller University. "Antibodies together with viral 'inducers' found to control HIV in mice." ScienceDaily. www.sciencedaily.com/releases/2014/08/140814191231.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins